Tilray Brands (TLRY) Shares Outstanding (Diluted Average) (2019 - 2026)

Tilray Brands (TLRY) reported Shares Outstanding (Diluted Average) of $112.7 million for Q1 2026, up 30.9% on a YoY basis from $86.1 million in Q1 2025, and up 2.11% quarter-over-quarter from $110.3 million in Q4 2025.

Tilray Brands (TLRY) Shares Outstanding (Diluted Average) (2019 - 2026) Analysis & Trends

Tilray Brands has reported Shares Outstanding (Diluted Average) for 8 years, with the latest figure at $112.7 million in Q1 2026.

  • For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 30.9% year-over-year to $112.7 million; the trailing twelve-month figure through Feb 2026 stood at $112.7 million (up 30.9% YoY), and the FY2025 full-year result was $890.3 million, up 19.89% from the prior year.
  • Shares Outstanding (Diluted Average) for Q1 2026 stood at $112.7 million, up from $110.3 million in the prior quarter.
  • The five-year high for Shares Outstanding (Diluted Average) was $1.1 billion in Q3 2025, with the low at $83.7 million in Q4 2024.
  • Historically, Shares Outstanding (Diluted Average) has averaged $559.9 million across 5 years, with a median of $615.5 million in 2023.
  • Annual changes were most pronounced in 2022 — Shares Outstanding (Diluted Average) jumped 90.69% — and 2025, when it slumped 88.59%.
  • Tilray Brands' Shares Outstanding (Diluted Average) stood at $611.7 million in 2022, then rose by 19.46% to $730.8 million in 2023, then sank by 88.54% to $83.7 million in 2024, then surged by 31.77% to $110.3 million in 2025, then grew by 2.11% to $112.7 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $112.7 million (Q1 2026), $110.3 million (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.18 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 422.40 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 47.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 103.40 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 506.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 228.36 Mn
10 Tilray Brands - - 54.95 Mn 112.68 Mn

Historic Data

Download Data
DateValue
Feb 28, 2026 112.68 Mn
Nov 30, 2025 110.34 Mn
Aug 31, 2025 1.06 Bn
May 31, 2025 890.33 Mn
Feb 28, 2025 86.08 Mn
Nov 30, 2024 83.74 Mn
Aug 31, 2024 875.44 Mn
May 31, 2024 742.65 Mn
Feb 29, 2024 754.44 Mn
Nov 30, 2023 730.77 Mn
Aug 31, 2023 691.19 Mn
May 31, 2023 617.98 Mn
Feb 28, 2023 615.53 Mn
Nov 30, 2022 611.71 Mn
Aug 31, 2022 575.30 Mn
May 31, 2022 481.22 Mn
Feb 28, 2022 478.05 Mn
Nov 30, 2021 460.25 Mn
Aug 31, 2021 449.40 Mn
May 31, 2021 269.55 Mn